{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:53:56Z","timestamp":1787741636316,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["R01AA020509"],"award-info":[{"award-number":["R01AA020509"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jsat.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T17:45:39Z","timestamp":1535478339000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management"],"prefix":"10.1016","volume":"94","author":[{"given":"Shannon R.","family":"Kenney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2018.08.011_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.011_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.011_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02791072.2010.10400696","article-title":"Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance","volume":"42","author":"Awgu","year":"2010","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.011_bb0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.08.011_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.jsat.2018.08.011_bb0030","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.08.011_bb0035","author":"Center for Behavioral Health Statistics and Quality"},{"issue":"2","key":"10.1016\/j.jsat.2018.08.011_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.011_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2018.08.011_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ADM.0000000000000057","article-title":"Factors affecting noncompliance with buprenorphine maintenance treatment","volume":"8","author":"Fareed","year":"2014","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2018.08.011_bb0055","series-title":"FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder [press release]","author":"Food and Drug Administration","year":"2017"},{"issue":"10","key":"10.1016\/j.jsat.2018.08.011_bb0060","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1046\/j.1360-0443.2002.00227.x","article-title":"Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: Protective effect of coping responses","volume":"97","author":"Gossop","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.08.011_bb0065","first-page":"CD002025","article-title":"Buprenorphine for the management of opioid withdrawal","volume":"3","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1016\/j.jsat.2018.08.011_bb0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ps.55.7.767","article-title":"Relationship between drug treatment services, retention, and outcomes","volume":"55","author":"Hser","year":"2004","journal-title":"Psychiatric Services"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2018.08.011_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"2 Suppl","key":"10.1016\/j.jsat.2018.08.011_bb0080","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: How to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.08.011_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/PPA.S4149","article-title":"Effect of shared decision-making on therapeutic alliance in addiction health care","volume":"2","author":"Joosten","year":"2008","journal-title":"Patient Preference and Adherence"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.011_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000126073","article-title":"Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status","volume":"77","author":"Joosten","year":"2008","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"14","key":"10.1016\/j.jsat.2018.08.011_bb0095","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2018.08.011_bb0100","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2018.08.011_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/11536020-000000000-00000","article-title":"Intravenous misuse of buprenorphine: Characteristics and extent among patients undergoing drug maintenance therapy","volume":"30","author":"Moratti","year":"2010","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.jsat.2018.08.011_bb0110","author":"Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.011_bb0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.011_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.jsat.2018.08.011_bb0125","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: Randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2018.08.011_bb0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.011_bb0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/clpt.2010.352","article-title":"Induction of opioid-dependent individuals onto buprenorphine and buprenorphine\/naloxone soluble-films","volume":"89","author":"Strain","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jsat.2018.08.011_bb0140","series-title":"Treatment Improvement Protocol (TIP) series. 43. HHS publication no. (SMA) 12-4214","author":"Substance Abuse and Mental Health Services Administration","year":"2005"},{"key":"10.1016\/j.jsat.2018.08.011_bb0145","series-title":"Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH series H-34, DHHS publication no. SMA 08\u20134343)","author":"Substance Abuse and Mental Health Services Administration","year":"2008"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.011_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2018.08.011_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"22","key":"10.1016\/j.jsat.2018.08.011_bb0160","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.08.011_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2009.03.008","article-title":"Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence","volume":"103","author":"White","year":"2009","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218301053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218301053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:21Z","timestamp":1760039301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218301053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":33,"alternative-id":["S0740547218301053"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.08.011","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}